Galmed Pharmaceuticals
Tel Aviv · Founded 2000
About Galmed Pharmaceuticals
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.
Company Facts
- Founded: 2000
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $112.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:GLMD
- Website: galmedpharma.com
- Phone: +972 3-693-8448
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/galmed-pharmaceuticals-140186 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.